Cargando…
Genome-scale metabolic modeling of responses to polymyxins in Pseudomonas aeruginosa
BACKGROUND: Pseudomonas aeruginosa often causes multidrug-resistant infections in immunocompromised patients, and polymyxins are often used as the last-line therapy. Alarmingly, resistance to polymyxins has been increasingly reported worldwide recently. To rescue this last-resort class of antibiotic...
Autores principales: | Zhu, Yan, Czauderna, Tobias, Zhao, Jinxin, Klapperstueck, Matthias, Maifiah, Mohd Hafidz Mahamad, Han, Mei-Ling, Lu, Jing, Sommer, Björn, Velkov, Tony, Lithgow, Trevor, Song, Jiangning, Schreiber, Falk, Li, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333913/ https://www.ncbi.nlm.nih.gov/pubmed/29688451 http://dx.doi.org/10.1093/gigascience/giy021 |
Ejemplares similares
-
Metabolic Responses to Polymyxin Treatment in Acinetobacter baumannii ATCC 19606: Integrating Transcriptomics and Metabolomics with Genome-Scale Metabolic Modeling
por: Zhu, Yan, et al.
Publicado: (2019) -
Integrated metabolomic and transcriptomic analyses of the synergistic effect of polymyxin–rifampicin combination against Pseudomonas aeruginosa
por: Mahamad Maifiah, Mohd Hafidz, et al.
Publicado: (2022) -
Global metabolic analyses identify key differences in metabolite levels between polymyxin-susceptible and polymyxin-resistant Acinetobacter baumannii
por: Mahamad Maifiah, Mohd Hafidz, et al.
Publicado: (2016) -
Synergistic Combination of Polymyxin B and Enrofloxacin Induced Metabolic Perturbations in Extensive Drug-Resistant Pseudomonas aeruginosa
por: Lin, Yu-Wei, et al.
Publicado: (2019) -
In silico genome-scale metabolic modeling and in vitro static time-kill studies of exogenous metabolites alone and with polymyxin B against Klebsiella pneumoniae
por: Chung, Wan Yean, et al.
Publicado: (2022)